In POEMS syndrome, the primary aim of treatment is to target plasma cells and suppress the production of the toxic monoclonal protein. Autologous stem cell transplantation (ASCT) [5], melphalan [6], immunomodulatory agents(thalidomide/lenalidomide) [7,8] and bortezomib, [9] etc., had good therapeutic effects in clinical application.